Literature DB >> 17383006

Janus faces of microglia in multiple sclerosis.

Patricia Sanders1, Jacques De Keyser.   

Abstract

Multiple sclerosis (MS) is the most common cause of neurological disability in young adults. The disease is characterized by inflammatory reactions, demyelination and axonal loss in the brain, spinal cord and optic nerves. Microglia seem to play an important role in the inflammatory processes in MS, since they are found in actively demyelinating lesions. Their role in the differentiation of T cells could led to the expansion of inflammation and tissue destruction. However, microglia are also involved in the termination of an inflammatory response and produce protective factors. To be able to therapeutically manipulate microglia, their exact function in the onset and development of MS needs to be clarified. This review provides an overview of the functions of the most important microglia-associated molecules in MS, being CD40, B7-1 and B7-2, interferon-gamma, tumor necrosis factor-alpha, chemokines, prostanoids, and nitric oxide.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17383006     DOI: 10.1016/j.brainresrev.2007.03.001

Source DB:  PubMed          Journal:  Brain Res Rev        ISSN: 0165-0173


  17 in total

1.  MiR-30a Positively Regulates the Inflammatory Response of Microglia in Experimental Autoimmune Encephalomyelitis.

Authors:  Xue Fang; Dingya Sun; Zhihong Wang; Zhongwang Yu; Weili Liu; Yingyan Pu; Dan Wang; Aijun Huang; Mingdong Liu; Zhenghua Xiang; Cheng He; Li Cao
Journal:  Neurosci Bull       Date:  2017-07-17       Impact factor: 5.203

2.  Regulator of G-protein Signaling (RGS)1 and RGS10 Proteins as Potential Drug Targets for Neuroinflammatory and Neurodegenerative Diseases.

Authors:  Jae-Kyung Lee; Josephine Bou Dagher
Journal:  AAPS J       Date:  2016-02-22       Impact factor: 4.009

Review 3.  Importance of oligodendrocyte protection, BBB breakdown and inflammation for remyelination.

Authors:  Jens Watzlawik; Arthur E Warrington; Moses Rodriguez
Journal:  Expert Rev Neurother       Date:  2010-03       Impact factor: 4.618

4.  Altered levels of STAT1 and STAT3 influence the neuronal response to interferon gamma.

Authors:  R Wesley Rose; Anna G Vorobyeva; Jason D Skipworth; Emmanuelle Nicolas; Glenn F Rall
Journal:  J Neuroimmunol       Date:  2007-11-19       Impact factor: 3.478

5.  Differentiation of C2D macrophage cells after adoptive transfer.

Authors:  Betsey E Potts; Marcia L Hart; Laura L Snyder; Dan Boyle; Derek A Mosier; Stephen K Chapes
Journal:  Clin Vaccine Immunol       Date:  2007-12-19

Review 6.  Toll-like receptors in multiple sclerosis.

Authors:  Michael K Racke; Paul D Drew
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

Review 7.  Microglial Phenotypes and Functions in Multiple Sclerosis.

Authors:  Elaine O'Loughlin; Charlotte Madore; Hans Lassmann; Oleg Butovsky
Journal:  Cold Spring Harb Perspect Med       Date:  2018-02-01       Impact factor: 6.915

8.  Inhibition of p53 transcriptional activity: a potential target for future development of therapeutic strategies for primary demyelination.

Authors:  Jiadong Li; Cristina A Ghiani; Jin Young Kim; Aixiao Liu; Juan Sandoval; Jean DeVellis; Patrizia Casaccia-Bonnefil
Journal:  J Neurosci       Date:  2008-06-11       Impact factor: 6.167

Review 9.  The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.

Authors:  Giulia Mallucci; Luca Peruzzotti-Jametti; Joshua D Bernstock; Stefano Pluchino
Journal:  Prog Neurobiol       Date:  2015-03-21       Impact factor: 11.685

10.  The CCL2 synthesis inhibitor bindarit targets cells of the neurovascular unit, and suppresses experimental autoimmune encephalomyelitis.

Authors:  Shujun Ge; Bandana Shrestha; Debayon Paul; Carolyn Keating; Robert Cone; Angelo Guglielmotti; Joel S Pachter
Journal:  J Neuroinflammation       Date:  2012-07-12       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.